Dr. Reddy's Laboratories received final approval for generic Avapro and Avalide tabletsTeva Pharmaceuticals, Mylan and Sandoz also received final approval from the US FDADr. Reddy's Laboratories received final approval for Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration for Irbesartan tablets in multiple strengths of 75 mg, 150 mg and 300 mg. The company also received final approval from the US FDA for its ANDA for Irbesartan and Hydrochlorothiazide tablets in multiple strengths of USP, 150/12.5mg and 300/12.5 mg.The drug was originally developed and marketed by Sanofi-Aventis under the brand name drug Avapro and Avalide respectively. Also, Avapro indicated for the treatment of hypertension and in patients with type 2 diabetic nephropathy, and Avalide is indicated for hypertension in patients not adequately controlled with a single drug, and as initial therapy in patients likely to need multiple drugs to achieve blood pressure controlNotably, Avapro tablets had U.S. sales of approximately USD 400.7 million for the 12 months ending June 30, 2012, and Avalide tablets had U.S. sales of approximately USD 117.4 million, according to IMS Health.Teva Pharmaceuticals, Mylan and Sandoz also received final approval for Irbesartan, Irbesartan and Hydrochlorothiazide ANDA's from the US FDA.